Medical/Pharmaceuticals
Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials
KYOTO, Japan, April 15, 2025 /PRNewswire/ -- Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tamibarotene-related clinical and non-clinical assets from Syros Pharmaceuticals, Inc. (Headquarters:Boston, MA;...
2025-04-15 13:20
2117
Wang Qunbin: Leveraging Innovation and Global Operational Strengths to Contribute "Fosun Power" to the Development of Hainan Free Trade Port
HONG KONG and SHANGHAI, April 15, 2025 /PRNewswire/ -- On April 14, the 2025 Hainan Free Trade Port Global Investment Promotion Conference was held inHaikou . Jointly hosted by the People's Government ofHainan Province and the Ministry of Commerce, the conference is one of the key events in the 20...
2025-04-15 12:05
3367
Chromatin Bioscience Signs Collaboration Agreement with Astellas
EDINBURGH, Scotland, April 14, 2025 /PRNewswire/ -- Chromatin Bioscience, a
leader in the design of synthetic promoters and gene control systems, is
pleased to announce a collaboration agreement with Astellas Pharma
2025-04-14 17:00
2688
PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets
Strategic Partnership Aims to Create Novel Drug Discovery Pipeline for Unmet Medical Needs by Combining PPI Control Technology with AI Drug Discovery Platform TOKYO, April 14, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company ...
2025-04-14 15:00
2375
MGI Tech Celebrates 10 Years of DNBSEQ™ Technology: Driving Genomics Forward with Speed, Scale, and Accessibility
SHENZHEN, China, April 13, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a
company committed to building core tools and technologies that drive innovation
in life science, proudly marks a decade since the commercialization of its
proprietaryDNBSEQ™ sequencing technology
2025-04-14 10:53
2702
CMEF Shanghai 2025 Wraps Up in Shanghai with Record-Breaking Innovations and Global Participation
SHANGHAI, April 14, 2025 /PRNewswire/ -- The 91st China International Medical Equipment Fair (CMEF) concluded onApril 11, 2025, in Shanghai, after featuring groundbreaking medical technologies from nearly 5,000 exhibitors and attracting hundreds of thousands of attendees from more than 150 countr...
2025-04-14 10:53
3639
Over 3 million children died from AMR-related infections in 2022, major study shows
A landmark study presented today at ESCMID Global 2025 has revealed that over 3 million children worldwide lost their lives in 2022 due to antimicrobial resistance (AMR)-related infections. VIENNA, April 12, 2025 /PRNewswire/ -- The study underscores the urgent need for both regional and global...
2025-04-13 06:01
3468
Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) published in Nature Medicine, a top international medical journal
CHENGDU, China, April 12, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that results from a Phase 3 registrational clinical study evaluating the novel TROP2 antibody drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) for the treatment o...
2025-04-12 17:20
4350
Patrick Tan appointed as Duke-NUS Dean to lead next era of medical innovation and education
SINGAPORE, April 11, 2025 /PRNewswire/ -- Duke-NUS Medical School has appointed ProfessorPatrick Tan as its next and fourth Dean, effective 1 January 2026, marking a new chapter for the School as it builds on its legacy of medical education, research and innovation. Prof Tan will serve as Dean-de...
2025-04-11 20:06
4208
Global First Engineered Exosome with INCI Name -- ImmVira Leads a New Era in International Cosmetic Ingredients
SUZHOU, China, April 10, 2025 /PRNewswire/ -- EonveLab, a subsidiary of ImmVira Group ("ImmVira," or the "Company"), recently announced that its in-house developed engineered exosome product, MVR-EX103, developed for treating superficial skin depressions, has successfully passed the review of th...
2025-04-11 13:19
3161
Florida Theranostics Brings Cutting-Edge United Imaging Digital PET/CT to Palm Beach County, Florida
The uMI Panorama™ from United Imaging is the first in Florida. HOUSTON, April 10, 2025 /PRNewswire/ -- United Imaging, a global manufacturer of modern medical imaging technology, will feature its uMI Panorama at a state-of-the-art new facility inJupiter, FL. Focused on patient-centered and preci...
2025-04-11 00:27
2347
Longevity and precision medicine driving the agenda at Abu Dhabi Global Health Week
* Global initiative addressing personalised and preventative health to be launched during the event ABU DHABI, UAE, April 10, 2025 /PRNewswire/ -- With rising global demand for more personalised and effective healthcare solutions, the Department of Health -Abu Dhabi (DoH) , the regulator of the...
2025-04-10 21:57
2811
Longevity and precision medicine driving the agenda at Abu Dhabi Global Health Week
* Global initiative addressing personalised and preventative health to be launched during the event ABU DHABI, UAE, April 10, 2025 /PRNewswire/ -- With rising global demand for more personalised and effective healthcare solutions, the Department of Health -Abu Dhabi (DoH) , the regulator of the...
2025-04-10 21:37
3627
Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer
CAMBRIDGE, Mass., April 10, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I TM), ranging from target validation and antibody discovery through preclinical research, today announced a research collaboration with Atossa ...
2025-04-10 20:00
2566
Belief BioMed and Takeda China jointly announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved
SHANGHAI, April 10, 2025 /PRNewswire/ -- Belief BioMed ("BBM") and Takeda China today jointly announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the National Medical Products Administration (NMPA) for the treatment of adult patients with mod...
2025-04-10 19:23
4018
Medtec Southeast Asia 2025 - The Southeast Asia's Premier Medical Device Design & Manufacturing Exhibition Debuts in Malaysia
KUALA LUMPUR, Malaysia, April 10, 2025 /PRNewswire/ -- Informa Markets announces the launch ofMedtec Southeast Asia 2025, the premier medical device design and manufacturing exhibition inSoutheast Asia, making its debut in Malaysia. The inaugural Medtec Southeast Asia 2025 exhibition will take p...
2025-04-10 16:58
4379
Fangzhou Showcases AI Governance Breakthroughs at Guangzhou Closed-Door Summit on Vertical-Specific AI Models
GUANGZHOU, China, April 9, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leading Internet healthcare solution provider, emerged as the sole digital health innovator invited to the Modern Industrial System Development Summit hosted by the Guangzhou Industrial Devel...
2025-04-10 11:07
4425
Harbour BioMed Appoints Youchen Chen as Chief Financial Officer
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , April 9, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics focusing on immunology and oncology, today announced the appointment of...
2025-04-10 10:00
4522
Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation
- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automation systemexpected to cover the entire PCR workforce, from sample pre-processing to result analysis. - Designed for 24-hour, seven-days-a-week, unattended, CURECA™ reflects the company's mission to ...
2025-04-09 21:00
3416
Ractigen's RAG-17 ALS Data Shines at AAN 2025: Earns Top Award, Phase I Advances
* Final results from an Investigator-Initiated Trial presented for the first time, demonstrating favorable safety, significant target engagement, and encouraging clinical & biomarker signals * Abstract honored with prestigious "Abstracts of Distinction" award by AAN Science Committee, recogni...
2025-04-09 20:00
3122
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 318 media titles]
2026-01-23 11:03
Agoda Launches Open-Source API Agent to Simplify MCP Server Integrations
[Picked up by 308 media titles]
2026-01-27 13:00
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 306 media titles]
2026-01-23 09:00Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
Nokia Strengthens Edge AI Capabilities Through Strategic Collaboration with Blaize on Hybrid Inference Solutions Across Asia Pacific Regions
[Picked up by 292 media titles]
2026-01-27 18:00
